Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients Caregivers Providers
Log In Ask a Question
PubMed This is a summary of 25 peer-reviewed journal articles Updated
Endocrinology · Macroprolactinemia

Macroprolactin: Is My High Prolactin A False Positive?

At a Glance

Macroprolactin is a harmless condition where normal prolactin molecules clump together with antibodies, causing a false high result on standard prolactin blood tests. A specialized PEG precipitation test can determine your true active prolactin levels and help rule out a pituitary tumor.

When a routine blood test shows high prolactin levels, it is completely normal to worry about a prolactinoma (a pituitary tumor). However, if your doctor has told you that your high levels are due to macroprolactin, it generally means you do not have a tumor [1]. Macroprolactinemia is a harmless condition that acts as a “false alarm” on standard blood tests, making it look like your prolactin is dangerously high when your levels of active prolactin are actually normal [2][3].

What is Macroprolactin?

Normally, prolactin circulates in your blood as small, single molecules (called monomeric prolactin), which are biologically active and interact with your body’s tissues [4].

Macroprolactin occurs when these normal prolactin molecules clump together with antibodies, specifically immunoglobulin G (IgG) [4][5]. This is a natural, harmless immune response where the body makes antibodies that happen to stick to prolactin [4]. Because these clumps are so large, they cannot easily leave the bloodstream, causing them to build up over time [4][6].

More importantly, because the prolactin is bound up in these clumps, it is biologically inactive [3]. This means the prolactin cannot interact with your tissues to cause true hyperprolactinemia symptoms—such as missing periods or breast milk production (galactorrhea) in women, low libido or erectile dysfunction in men, or infertility [3][7].

Why Standard Tests Cause a False Alarm

Standard prolactin blood tests are designed to measure the total amount of prolactin in your blood [8]. They cannot always tell the difference between normal, active prolactin and the large, inactive macroprolactin clumps [9]. Furthermore, different laboratory machines and brands react differently to macroprolactin, which explains why your levels might look exceptionally high at one clinic but much lower at another [9].

When a laboratory runs a standard test, the macroprolactin triggers the assay, making the total prolactin number look artificially high [10]. This is known medically as pseudohyperprolactinemia (false high prolactin) [11]. Studies show that depending on the screening criteria, between 5% and 40% of people told they have high prolactin actually just have harmless macroprolactin [12][13]. Misdiagnosing this false alarm as a true prolactinoma can lead to unnecessary fear, costly MRI scans, and inappropriate treatment with medications [2][14].

The PEG Precipitation Test: Finding the Truth

To figure out if your high prolactin is real or just a false alarm, labs use a specialized screening method called the polyethylene glycol (PEG) precipitation test [15][16]. Practically, your doctor may be able to request this test on the blood sample the lab already has, or they may ask you to return for a quick, routine fasting blood draw [17].

Here is how the PEG test works:

  • The lab adds a chemical called PEG to your blood sample [17].
  • PEG acts like a sponge that forces the large macroprolactin clumps to precipitate (sink to the bottom) [5].
  • The lab then measures the clear fluid left at the top (the supernatant), which contains only your normal, active prolactin [15][17].

If your active prolactin level is normal after the PEG test, it confirms that your originally high blood test was just a false alarm caused by macroprolactin [18][19]. This result typically rules out the need for pituitary MRIs or tumor medications [20][21].

Can You Have Both?

While a macroprolactin diagnosis is excellent news, it is medically possible to have both macroprolactinemia and a real prolactinoma at the same time [22][23]. This is why your doctor will look at the exact numbers from your PEG test [24].

If the remaining active prolactin is still elevated after the macroprolactin is removed, your doctor will want to investigate further [25]. An MRI may also be recommended if you are experiencing classic hormonal symptoms (like unexplained milk production, missing periods, or severe loss of libido) or mass-effect symptoms from a physical tumor, such as frequent headaches or changes in your peripheral vision [25][3]. However, if your post-PEG prolactin is completely normal and you feel well, you can generally breathe a sigh of relief [19][20].

Common questions in this guide

What is macroprolactin?
Macroprolactin is a harmless cluster of normal prolactin molecules bound to antibodies in your blood. Because these clumps are large and biologically inactive, they do not cause hormonal symptoms, but they can trigger falsely high results on standard blood tests.
Why did my blood test show high prolactin if I don't have a tumor?
Standard prolactin tests measure the total amount of prolactin in your blood and cannot always tell the difference between normal active prolactin and inactive macroprolactin clumps. This frequently results in a false alarm called pseudohyperprolactinemia.
What is the PEG precipitation test for prolactin?
The PEG test is a specialized lab procedure used to separate inactive macroprolactin clumps from active prolactin in your blood sample. This test reveals your true active prolactin levels, helping your doctor confirm if your high reading was just a false positive.
Can you have macroprolactin and a prolactinoma at the same time?
Yes, it is medically possible to have harmless macroprolactinemia and a true prolactinoma at the same time. If your active prolactin remains elevated after a PEG test, or if you have classic hormonal symptoms, your doctor will likely investigate further.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What was my active (monomeric) prolactin level specifically, after the PEG precipitation test was run?
  2. 2.Does our lab automatically screen for macroprolactin when a high total prolactin is detected, or do we need to request a PEG test specifically?
  3. 3.Given my post-PEG active prolactin results and my physical symptoms, can we officially rule out a prolactinoma?
  4. 4.Do I need any routine follow-up testing to monitor my prolactin, or can we safely close this investigation without treatment?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

Related questions

Can Cabergoline Cause a CSF Leak? | Inciteful MedDoes Cabergoline Cause Impulse Control Disorders?Cabergoline vs Bromocriptine for Prolactinoma TreatmentWhy Does a Giant Prolactinoma Show Normal Blood Tests?Is Prolactinoma Genetic? MEN1, AIP & Hereditary RiskIs High Prolactin Caused by Medication or a Prolactinoma?What Are the Emergency Signs of Pituitary Apoplexy?Can I Get Pregnant With a Prolactinoma? Is Medication Safe?Does a Prolactinoma Cause Bone Loss and Osteoporosis?Why Are Prolactinomas Diagnosed Later in Men?What is the Recovery Time for Prolactinoma Surgery?Can a Large Prolactinoma Affect Your Other Hormones?When Can I Stop Taking Cabergoline for Prolactinoma?Why Do I Need an Echocardiogram on Cabergoline?

References

References (25)
  1. 1

    Macroprolactinemia in patients with hyperprolactinemia: an experience from a single tertiary center.

    Chutpiboonwat P, Yenpinyosuk K, Sridama V, et al.

    The Pan African medical journal 2020; (36()):8 doi:10.11604/pamj.2020.36.8.22923.

    PMID: 32550971
  2. 2

    Macroprolactinemia: a mini-review and update on clinical practice.

    Koniares K, Benadiva C, Engmann L, et al.

    F&S reports 2023; (4(3)):245-250 doi:10.1016/j.xfre.2023.05.005.

    PMID: 37719092
  3. 3

    A Case of Screening Macroprolactinemia Using Polyethylene Glycol Precipitation Method.

    Li G, Shan N, Wang Q

    Clinical laboratory 2025; (71(3)) doi:10.7754/Clin.Lab.2024.241008.

    PMID: 40066536
  4. 4

    Persistent Idiopathic Prolactin Elevation Merits Macroprolactin Estimation: A Case Report and Review of Literature.

    Gautam K, Cherian KE, Jose A, et al.

    Journal of human reproductive sciences 2021; (14(2)):206-210 doi:10.4103/jhrs.jhrs_168_20.

    PMID: 34316240
  5. 5

    Circulating macroprolactin exhibits molecular heterogeneity and is not exclusively an antibody complex.

    Quynh N Nguyen K, Langevin RH, McPhaul MJ, Hashim IA

    Clinica chimica acta; international journal of clinical chemistry 2021; (514()):90-95 doi:10.1016/j.cca.2020.12.018.

    PMID: 33359057
  6. 6

    Evaluation of autoantibodies and immunoglobulin G subclasses in women with suspected macroprolactinemia.

    Yu C, Fan F, Hu S, et al.

    Journal of clinical laboratory analysis 2020; (34(11)):e23456 doi:10.1002/jcla.23456.

    PMID: 32597541
  7. 7

    Laboratory and clinical significance of macroprolactinemia in women with hyperprolactinemia.

    Kasum M, Orešković S, Čehić E, et al.

    Taiwanese journal of obstetrics & gynecology 2017; (56(6)):719-724 doi:10.1016/j.tjog.2017.10.002.

    PMID: 29241908
  8. 8

    Biochemical diagnosis in prolactinomas: some caveats.

    Petersenn S

    Pituitary 2020; (23(1)):9-15 doi:10.1007/s11102-019-01024-z.

    PMID: 31873848
  9. 9

    Cross-reactivity in assays for prolactin and optimum screening policy for macroprolactinaemia.

    Smith TP, Kelly S, Fahie-Wilson MN

    Clinical chemistry and laboratory medicine 2022; (60(9)):1365-1372 doi:10.1515/cclm-2022-0459.

    PMID: 35708266
  10. 10

    [Misleading diagnosis of hyperprolactinemia in women].

    Paepegaey AC, Veron L, Wimmer MC, Christin-Maitre S

    Gynecologie, obstetrique & fertilite 2016; (44(3)):181-6.

    PMID: 26966035
  11. 11

    Establishment of reference intervals of monomeric prolactin to identify macroprolactinemia in Chinese patients with increased total prolactin.

    Hu Y, Ni J, Zhang B, et al.

    BMC endocrine disorders 2021; (21(1)):197 doi:10.1186/s12902-021-00861-z.

    PMID: 34620143
  12. 12

    Metoclopramide Test in Hyperprolactinemic Women With Polycystic Ovarian Syndrome: Old Wine Into New Bottles?

    Rodier C, Courbière B, Fernandes S, et al.

    Frontiers in endocrinology 2022; (13()):832361 doi:10.3389/fendo.2022.832361.

    PMID: 35250884
  13. 13

    Prevalence and reproductive manifestations of macroprolactinemia.

    Kalsi AK, Halder A, Jain M, et al.

    Endocrine 2019; (63(2)):332-340 doi:10.1007/s12020-018-1770-6.

    PMID: 30269265
  14. 14

    Frequency of Macroprolactin in Hyperprolactinemia.

    Sherazi NA, Baig MZ, Khan AH

    Journal of the College of Physicians and Surgeons--Pakistan : JCPSP 2018; (28(2)):93-97 doi:10.29271/jcpsp.2018.02.93.

    PMID: 29394965
  15. 15

    Optimization of a Screening Method for Macroprolactinemia.

    Yang W, Guo Z, Zhou Y, et al.

    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2021; (1175()):122723 doi:10.1016/j.jchromb.2021.122723.

    PMID: 33989987
  16. 16

    Macroprolactinemia Detection by Magnetically Assisted Polyethylene Glycol Precipitation: Potential for Automation.

    Smith T, Stern E, Tan E, et al.

    The journal of applied laboratory medicine 2020; (5(3)):494-505 doi:10.1093/jalm/jfaa015.

    PMID: 32445359
  17. 17

    Isolated elevation of aspartate aminotransferase (AST) in an asymptomatic patient due to macro-AST.

    González Raya A, Coca Zúñiga R, Martín Salido E

    Journal of clinical laboratory analysis 2019; (33(2)):e22690 doi:10.1002/jcla.22690.

    PMID: 30320474
  18. 18

    Prolactin Biology and Laboratory Measurement: An Update on Physiology and Current Analytical Issues.

    Saleem M, Martin H, Coates P

    The Clinical biochemist. Reviews 2018; (39(1)):3-16.

    PMID: 30072818
  19. 19

    Macro-Aspartate Aminotransferase and Its Laboratory Detection: A Case Report.

    Aleknavičiūtė-Valienė G, Černiauskas L, Riauka M, Vitkus D

    Acta medica Lituanic 2023; (30(2)):181-187 doi:10.15388/Amed.2023.30.2.10.

    PMID: 38516513
  20. 20

    Comparison of PEG precipitation and ultrafiltration treatment for serum macroprolactin in Chinese patients with hyperprolactinemia.

    Ke X, Wang L, Duan L, et al.

    Clinica chimica acta; international journal of clinical chemistry 2023; (544()):117358 doi:10.1016/j.cca.2023.117358.

    PMID: 37086942
  21. 21

    Global Prevalence of Macroprolactinemia among Patients with Hyperprolactinemia: A Systematic Review and Meta-Analysis.

    Che Soh NAA, Yaacob NM, Omar J, et al.

    International journal of environmental research and public health 2020; (17(21)) doi:10.3390/ijerph17218199.

    PMID: 33171973
  22. 22

    Macroprolactin screening in 464 patients with hyperprolactinaemia.

    Lim MH, Ho CKM

    The Malaysian journal of pathology 2022; (44(2)):261-267.

    PMID: 36043589
  23. 23

    Macroprolactin: searching for a needle in a haystack?

    Lippi G, Plebani M

    Clinical chemistry and laboratory medicine 2016; (54(4)):519-22.

    PMID: 26845727
  24. 24

    A new criteria for screening macroprolactinemia using polyethylene glycol treatment combined with different assays for prolactin.

    Chen YJ, Song GZ, Wang ZN

    European review for medical and pharmacological sciences 2016; (20(9)):1788-94.

    PMID: 27212171
  25. 25

    Macroprolactinemia and Empty Sella Syndrome.

    Taieb A, Maha KN, El Abed YH, et al.

    The Pan African medical journal 2017; (27()):278 doi:10.11604/pamj.2017.27.278.11361.

    PMID: 29187947

This page explains macroprolactin and prolactin blood test interpretation for educational purposes only. Your endocrinologist or primary care doctor is the best source for analyzing your specific lab results.

Get notified when new evidence is published on Prolactinoma.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.